FEZF1
Basic information
Region (hg38): 7:122301303-122310691
Previous symbols: [ "ZNF312B" ]
Links
Phenotypes
GenCC
Source:
- hypogonadotropic hypogonadism 22 with or without anosmia (Strong), mode of inheritance: AR
- hypogonadotropic hypogonadism 22 with or without anosmia (Moderate), mode of inheritance: AR
- Kallmann syndrome (Supportive), mode of inheritance: AD
- hypogonadotropic hypogonadism 22 with or without anosmia (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Hypogonadotropic hypogonadism 22 with or without anosmia | AR | Endocrine | In Hypogonadotropic hypogonadism, surveillance in adolescence related to sexual maturation is indicated, as is monitoring of bone mineral density in order to allow early detection and treatment of disease; In order to induce and maintain secondary sex characteristics, gradually increasing doses of gonadal steroids (females: estrogen/progestin; males: testosterone/hCG) can be beneficial; Related to fertility, endocrinologic therapy (females: recombinant hCG or pulsatile GnRH therapy; males: hCG/HMG/recombinant FSH or pulsatile GnRH therapy) may be effective, though IVF may be required | Endocrine; Neurologic | 25192046 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FEZF1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 18 | 19 | ||||
missense | 32 | 37 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 13 | 16 | 29 | |||
Total | 0 | 0 | 32 | 36 | 17 |
Variants in FEZF1
This is a list of pathogenic ClinVar variants found in the FEZF1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-122301727-T-TA | Likely benign (Nov 22, 2019) | |||
7-122302003-G-A | Likely benign (Jun 23, 2023) | |||
7-122302008-C-T | Inborn genetic diseases | Uncertain significance (Jul 30, 2023) | ||
7-122302010-T-C | Inborn genetic diseases | Uncertain significance (Nov 08, 2022) | ||
7-122302028-A-C | Inborn genetic diseases | Uncertain significance (May 14, 2024) | ||
7-122302032-G-A | Inborn genetic diseases | Uncertain significance (May 13, 2024) | ||
7-122302032-G-T | Inborn genetic diseases | Uncertain significance (Dec 13, 2021) | ||
7-122302052-G-T | Inborn genetic diseases | Uncertain significance (Jul 14, 2021) | ||
7-122302075-C-T | not specified • FEZF1-related disorder | Benign (Mar 12, 2022) | ||
7-122302076-G-A | Inborn genetic diseases | Uncertain significance (Sep 27, 2021) | ||
7-122302082-T-G | Amenorrhea | Likely benign (Dec 10, 2018) | ||
7-122302102-C-T | FEZF1-related disorder | Likely benign (Mar 22, 2023) | ||
7-122302107-C-G | Uncertain significance (Jul 30, 2022) | |||
7-122302205-T-C | Inborn genetic diseases | Uncertain significance (Jun 22, 2024) | ||
7-122302239-C-T | Inborn genetic diseases | Uncertain significance (Dec 01, 2022) | ||
7-122302261-G-A | not specified • FEZF1-related disorder | Benign/Likely benign (Dec 23, 2021) | ||
7-122302261-G-C | Likely benign (Dec 21, 2023) | |||
7-122302301-T-G | Inborn genetic diseases | Uncertain significance (Mar 25, 2024) | ||
7-122302388-GA-G | Benign (Oct 21, 2018) | |||
7-122302472-A-G | Benign (Jun 28, 2019) | |||
7-122302567-A-G | Benign (Aug 09, 2018) | |||
7-122302620-C-A | Benign (Aug 09, 2018) | |||
7-122302778-G-GACA | Benign (Mar 31, 2019) | |||
7-122302784-T-C | Benign (Dec 12, 2023) | |||
7-122302793-G-C | Benign (Jan 31, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FEZF1 | protein_coding | protein_coding | ENST00000442488 | 4 | 9298 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.950 | 0.0495 | 125742 | 0 | 6 | 125748 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.29 | 210 | 270 | 0.779 | 0.0000121 | 3110 |
Missense in Polyphen | 63 | 102.02 | 0.61755 | 1263 | ||
Synonymous | 0.162 | 113 | 115 | 0.981 | 0.00000548 | 957 |
Loss of Function | 3.20 | 1 | 13.9 | 0.0722 | 6.07e-7 | 176 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.0000441 | 0.0000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000655 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription repressor. Involved in the axonal projection and proper termination of olfactory sensory neurons (OSN). Plays a role in rostro-caudal patterning of the diencephalon and in prethalamic formation. Expression is required in OSN to cell-autonomously regulate OSN axon projections. Regulates non-cell-autonomously the layer formation of the olfactory bulb development and the interneurons. May be required for correct rostral migration of the interneuron progenitors (By similarity). {ECO:0000250}.;
- Pathway
- Olfactory bulb development and olfactory learning
(Consensus)
Recessive Scores
- pRec
- 0.0948
Intolerance Scores
- loftool
- 0.395
- rvis_EVS
- -0.01
- rvis_percentile_EVS
- 53.19
Haploinsufficiency Scores
- pHI
- 0.354
- hipred
- Y
- hipred_score
- 0.808
- ghis
- 0.420
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.887
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fezf1
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cellular phenotype; craniofacial phenotype; taste/olfaction phenotype; growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- fezf1
- Affected structure
- hypothalamus development
- Phenotype tag
- abnormal
- Phenotype quality
- disrupted
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;neuron migration;axon guidance;negative regulation of cell population proliferation;olfactory bulb development;forebrain anterior/posterior pattern specification;cell dedifferentiation;positive regulation of neuron differentiation;positive regulation of transcription, DNA-templated
- Cellular component
- nucleus;cytosol
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;metal ion binding